Oncology Features

A review of the latest clinical trial data and medical advances at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) in Yokohama, Japan.

Around 7,100 women are diagnosed in the UK with ovarian cancer each year. Read the latest on developments in the diagnosis and management of ovarian cancer.

This section reviews the latest news and reports on medical advances including data from the European Society for Medical Oncology (ESMO) Congress held in Madrid, Spain.

The ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) features updates in the diagnosis, staging and prognosis assessment, treatment of loco-regional recurrence and metastatic disease, as well as treatment of specific breast cancer subtypes.

In the UK, the Liverpool Care Pathway for the Dying Patient (LCP) was developed to translate the ‘hospice care practice’ experience into other healthcare settings. Recently the LCP as a tool has drawn many critics both from the medical and political fraternities.

Malignant hypercalcaemia is a relatively common occurrence in patients with cancer particularly in the latter stages and carries with it a poor prognosis. Hypercalcaemia itself can be life-threatening and the symptoms distressing.

Bladder cancer is the 9th most common cancer diagnosis worldwide. At initial diagnosis, 30% of bladder cancer cases are already diagnosed as muscle-invasive disease (MIBC).

Bladder cancer is the seventh most common cancer in the UK and is the fourth most common cancer in UK men.

This section reviews the latest news and reports on medical advances including data from the American Society for Clinical Oncology (ASCO), Chicago, USA

Bladder cancer is the seventh most common cancer in the UK and is the fourth most common cancer in UK men. Bladder cancer is where a tumour develops in the lining of the bladder.